Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial-Reference-Cited by-同舟云学术

Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial

Published:2019-09-14 Issue:6 Volume:84 Page:1201-1208
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Luu Thehang,Frankel Paul,Beumer Jan H.,Lim Dean,Cristea Mihaela,Appleman Leonard J.,Lenz Heinz J.,Gandara David R.,Kiesel Brian F.,Piekarz Richard L.,Newman Edward M.^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03955-7.pdf

Reference33 articles.

1. Plumb JA et al (2003) Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101. Mol Cancer Ther 2(8):721–728

2. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92(15):1210–1216

3. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1(3):181–193

4. Lippman SM et al (1992) 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84(4):241–245

5. Lippman SM et al (1993) 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst 85(6):499–500

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The strategies to cure cancer patients by eradicating cancer stem-like cells;Molecular Cancer;2023-10-18

2. Anticancer clinical efficiency and stochastic mechanisms of belinostat;Biomedicine & Pharmacotherapy;2023-09

3. Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response;Cancers;2023-08-07

4. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment;Cancers;2022-11-30

5. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy;Journal of Gastroenterology;2022-09-01